Additionally, the activation of the PI3K/AKT/mTOR pathway through the detection of associated genes and protein expression was linked to lower overall survival (OS) and disease-free survival (DFS) in 50–80 % of AML patients [6,9]. Here, AKT1 is linked to acute myeloid leukemia.